Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies

INTRODUCTION: We sought to identify and compare treatment response groups based on individual patient responses (rather than group mean response) over time on the Clinical Disease Activity Index (CDAI) for rheumatoid arthritis (RA), in patients treated with baricitinib 4-mg in 4 phase 3 studies. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C., Chen, Yun-Fei, Pope, Janet, Weinblatt, Michael, Mysler, Eduardo, Rubbert-Roth, Andrea, Jia, Bochao, Sun, Luna, Liu, Yushi, Holzkämper, Thorsten, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011235/
https://www.ncbi.nlm.nih.gov/pubmed/36662442
http://dx.doi.org/10.1007/s40744-022-00529-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011235/
https://www.ncbi.nlm.nih.gov/pubmed/36662442
http://dx.doi.org/10.1007/s40744-022-00529-7

Ejemplares similares